Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2013 Nov 30;845:726-35. doi: 10.1124/mol.113.087502.
Show Gene links
Show Anatomy links
MONNA, a potent and selective blocker for transmembrane protein with unknown function 16/anoctamin-1.
Oh SJ
,
Hwang SJ
,
Jung J
,
Yu K
,
Kim J
,
Choi JY
,
Hartzell HC
,
Roh EJ
,
Lee CJ
.
???displayArticle.abstract???
Transmembrane protein with unknown function 16/anoctamin-1 (ANO1) is a protein widely expressed in mammalian tissues, and it has the properties of the classic calcium-activated chloride channel (CaCC). This protein has been implicated in numerous major physiological functions. However, the lack of effective and selective blockers has hindered a detailed study of the physiological functions of this channel. In this study, we have developed a potent and selective blocker for endogenous ANO1 in Xenopus laevis oocytes (xANO1) using a drug screening method we previously established (Oh et al., 2008). We have synthesized a number of anthranilic acid derivatives and have determined the correlation between biological activity and the nature and position of substituents in these derived compounds. A structure-activity relationship revealed novel chemical classes of xANO1 blockers. The derivatives contain a --NO₂ group on position 5 of a naphthyl group-substituted anthranilic acid, and they fully blocked xANO1 chloride currents with an IC₅₀ < 10 μM. The most potent blocker, N-((4-methoxy)-2-naphthyl)-5-nitroanthranilic acid (MONNA), had an IC₅₀ of 0.08 μM for xANO1. Selectivity tests revealed that other chloride channels such as bestrophin-1, chloride channel protein 2, and cystic fibrosis transmembrane conductance regulator were not appreciably blocked by 10∼30 μM MONNA. The potent and selective blockers for ANO1 identified here should permit pharmacological dissection of ANO1/CaCC function and serve as potential candidates for drug therapy of related diseases such as hypertension, cystic fibrosis, bronchitis, asthma, and hyperalgesia.
Barish,
A transient calcium-dependent chloride current in the immature Xenopus oocyte.
1983, Pubmed,
Xenbase
Barish,
A transient calcium-dependent chloride current in the immature Xenopus oocyte.
1983,
Pubmed
,
Xenbase
Caputo,
TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity.
2008,
Pubmed
Cho,
The calcium-activated chloride channel anoctamin 1 acts as a heat sensor in nociceptive neurons.
2012,
Pubmed
Greenwood,
Properties of a Cl- current activated by cell swelling in rabbit portal vein vascular smooth muscle cells.
1998,
Pubmed
Greenwood,
Overlapping pharmacology of Ca2+-activated Cl- and K+ channels.
2007,
Pubmed
Hartzell,
Calcium-activated chloride channels.
2005,
Pubmed
Huang,
Studies on expression and function of the TMEM16A calcium-activated chloride channel.
2009,
Pubmed
Huang,
Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction.
2012,
Pubmed
Kuruma,
Bimodal control of a Ca(2+)-activated Cl(-) channel by different Ca(2+) signals.
2000,
Pubmed
,
Xenbase
Miledi,
A calcium-dependent transient outward current in Xenopus laevis oocytes.
1982,
Pubmed
,
Xenbase
Namkung,
TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells.
2011,
Pubmed
Oh,
Development of selective blockers for Ca²(+)-activated Cl channel using Xenopus laevis oocytes with an improved drug screening strategy.
2008,
Pubmed
,
Xenbase
Park,
Bestrophin-1 encodes for the Ca2+-activated anion channel in hippocampal astrocytes.
2009,
Pubmed
Qu,
Functional geometry of the permeation pathway of Ca2+-activated Cl-channels inferred from analysis of voltage-dependent block.
2001,
Pubmed
,
Xenbase
Reinsprecht,
Blockade of capacitive Ca2+ influx by Cl- channel blockers inhibits secretion from rat mucosal-type mast cells.
1995,
Pubmed
Schroeder,
Expression cloning of TMEM16A as a calcium-activated chloride channel subunit.
2008,
Pubmed
,
Xenbase
Schultheiss,
Multiple action sites of flufenamate on ion transport across the rat distal colon.
2000,
Pubmed
Shaw,
Action of diphenylamine carboxylate derivatives, a family of non-steroidal anti-inflammatory drugs, on [Ca2+]i and Ca(2+)-activated channels in neurons.
1995,
Pubmed
Verkman,
Chloride channels as drug targets.
2009,
Pubmed
Wang,
Unexpected and differential effects of Cl- channel blockers on the Kv4.3 and Kv4.2 K+ channels. Implications for the study of the I(to2) current.
1997,
Pubmed
,
Xenbase
Xiao,
Voltage- and calcium-dependent gating of TMEM16A/Ano1 chloride channels are physically coupled by the first intracellular loop.
2011,
Pubmed
Xu,
Volume-sensitive chloride current activated by hyposmotic swelling in antral gastric myocytes of the guinea-pig.
1997,
Pubmed
Yang,
TMEM16A confers receptor-activated calcium-dependent chloride conductance.
2008,
Pubmed
,
Xenbase
